Clinical Trial: Page 2

ChromaCode partners with the Medical College of Georgia on NSCLC assay validation
By LabPulse.com staff writers
ChromaCode announced a partnership with the Medical College of Georgia to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.
March 21, 2024
Cancer Lung Social
Novartis presents first results of SMART spinal muscular atrophy study
By LabPulse.com staff writers
Company presents new data from a clinical study, called the SMART study, of its gene therapy in previously treated patients and a broader patient population.
March 5, 2024
Clinical Trial Data Network Social
‘Remarkable’ results in lupus patients spark speculation CAR-T may cure autoimmunity
By Nick Paul Taylor
The generation of “remarkable” results in lupus patients has sparked speculation about the potential for chimeric antigen receptor T-cell (CAR-T cell) therapy to cure autoimmune diseases.
February 23, 2024
T Cell Social
U.K. trial for mRNA-based cancer therapy begins
By Matt Limb
Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.
February 7, 2024
Messenger Rna M Rna Social
Sensorion receives clinical trial approval for congenital deafness gene therapy
By LabPulse.com staff writers
French biotech firm Sensorion has received approval to initiate a phase I and II clinical trial in France of SENS-501 (the OTOF-GT program), its gene therapy for gene-mediated hearing impairment.
January 22, 2024
Clinical Trial Data Network Social
Labcorp continues clinical trial drive
By LabPulse.com staff writers
In another move to build a strong foundation for its clinical trial testing business, Labcorp has announced that it will collaborate with Hawthorne Effect for decentralized clinical trial support at home and in the community.
January 10, 2024
Labcorp Rtp 10 Med Res 950h 6x4 Social
AI-powered blood test supports risk stratification of heart disease patients
By Nick Paul Taylor
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
Heart Pulmonary Trunk Social
PLK1 inhibitors show promise for inflammatory disease treatment, study shows
By Matt Limb
A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.
November 14, 2023
Molecule Social
Targeting feeder cells reverses prostate cancer’s resistance to treatment in study
By Matt Limb
Scientists have found a way to reverse prostate cancer’s resistance to drugs in research, which they say could have a broad impact across multiple cancer types.
October 24, 2023
Cancer Cells Prostate Social
Study launched on early intervention with immune modulators in COVID-19
By LabPulse.com staff writers
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
HIV vaccine trial begins enrollment in U.S., South Africa
By LabPulse.com staff writers
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
By Nick Paul Taylor
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
Previous Page
Page 2 of 19
Next Page